Merck & Co Inc【0QAH】株式ニュース

	リアルタイム株価	レベル2
Forex

TOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug deal

Shares in Japan's Daiichi Sankyo Co Ltd soared on Friday after the pharma group announced a major cancer drug deal w ...

Drugmakers agree to US government price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...

UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan

AstraZeneca PLC and Merck & Co Inc on Thursday jointly said its Lynparza treatments have been approved in Japan. Mer ...

Merck & Co second quarter revenue up; profit falls acquisition costs

Merck & Co Inc on Tuesday said revenue increased in the second quarter, but profit suffered due to the cost of buying ...

Merck says latest trial data shows Keytruda meets survival endpoint

Merck & Co Inc on Friday said trial data showed its Keytruda treatment met a primary endpoint of progression-free sur ...

Merck and Astra's Lynparza prostate cancer treatment gets US approval

Merck & Co Inc on Thursday said the US Food & Drug Administration approved its Lynparza treatment, developed with Ast ...

AstraZeneca "disappointed" with US ODAC's guidance on Lynparza

AstraZeneca PLC on Friday said the US Food & Drug Administration's Oncologic Drugs Advisory Committee has recognised ...

Merck & Co beats on first-quarter revenue and hails "advancements"

Merck & Co Inc on Thursday said that first-quarter revenue declined, following a fall in sales of Covid-19 antiviral ...

Merck's Keytruda combination sees positive results in cancer trial

Merck & Co Inc on Friday said that its Keytruda and chemotherapy combination significantly improved overall survival ...

US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo

AstraZeneca PLC and Merck & Co Inc said on Thursday that the US Food & Drug Administration will convene a meeting of ...

IN BRIEF: EU refuses marketing recommendation for Merck's Lagevrio

New Jersey, US-based pharmaceutical firm - Alongside Miami-based biotechnology company Ridgeback Biotherapeutics, anno ...

TOP NEWS: Merck & Co annual net profit up but drops in fourth-quarter

Merck & Co Inc on Thursday said annual net profit, sales and earning per share were up, although net profit and EPS d ...

Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment

Daiichi Sankyo Co Ltd on Monday said the first patient has been dosed in its Tropion-Lung07 phase 3 trial, which is e ...

AstraZeneca wins two new approvals in EU for cancer drugs

AstraZeneca PLC on Wednesday said it won two new drug approvals in the European Union for Imfinzi and Lynparza to tre ...

FDA accepts Astellas, Seagen and Merck's combo for priority review

Pharmaceutical firms Astellas Pharma Inc, Seagen Inc and Merck & Co Inc jointly announced on Tuesday that the US Food ...

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Merck & Co Inc (0QAH)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

0QAH ニュース

TOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug deal

Drugmakers agree to US government price talks amid pushback

UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan

Merck & Co second quarter revenue up; profit falls acquisition costs

Merck says latest trial data shows Keytruda meets survival endpoint

Merck and Astra's Lynparza prostate cancer treatment gets US approval

AstraZeneca "disappointed" with US ODAC's guidance on Lynparza

Merck & Co beats on first-quarter revenue and hails "advancements"

Merck's Keytruda combination sees positive results in cancer trial

US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo

IN BRIEF: EU refuses marketing recommendation for Merck's Lagevrio

TOP NEWS: Merck & Co annual net profit up but drops in fourth-quarter

Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment

AstraZeneca wins two new approvals in EU for cancer drugs

FDA accepts Astellas, Seagen and Merck's combo for priority review

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Merck & Co Inc (0QAH) ニュース

Merck & Co Inc (0QAH)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

0QAH ニュース

TOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug deal

Drugmakers agree to US government price talks amid pushback

UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan

Merck & Co second quarter revenue up; profit falls acquisition costs

Merck says latest trial data shows Keytruda meets survival endpoint

Merck and Astra's Lynparza prostate cancer treatment gets US approval

AstraZeneca "disappointed" with US ODAC's guidance on Lynparza

Merck & Co beats on first-quarter revenue and hails "advancements"

Merck's Keytruda combination sees positive results in cancer trial

US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo

IN BRIEF: EU refuses marketing recommendation for Merck's Lagevrio

TOP NEWS: Merck & Co annual net profit up but drops in fourth-quarter

Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment

AstraZeneca wins two new approvals in EU for cancer drugs

FDA accepts Astellas, Seagen and Merck's combo for priority review

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％